Works matching DE "GENENTECH Inc."

Results: 237

News from the FDA.

Published in:

Patient Care (Print), 2004, v. 38, n. 5, p. 9

By:

Pennachio, Dorothy L.

Publication type:

Article

Prescribing update.

Published in:: Patient Care (Print), 2000, v. 34, n. 15, p. 12
Publication type:: Article

University of California sues Genentech.

Published in:: Nature, 1997, v. 388, n. 6639, p. 220
Publication type:: Article

Genentech co-founder quits.

Published in:: Nature, 1996, v. 384, n. 6610, p. 607
Publication type:: Article

Single amino-acid makes big difference in patent court.

Published in:

Nature, 1994, v. 372, n. 6502, p. 123, doi. 10.1038/372123a0

By:

Swinbanks, David

Publication type:

Article

Genentech agrees to drop promotion of growth hormone.

Published in:

Nature, 1994, v. 371, n. 6498, p. 550, doi. 10.1038/371550b0

By:

Macilwain, Colin

Publication type:

Article

Myriad: Spearheading a hunt for genes.

Published in:

Nature, 1994, v. 371, n. 6495, p. 271, doi. 10.1038/371271b0

By:

D.G.

Publication type:

Article

Clone your own legend.

Published in:

Nature, 1993, v. 362, n. 6419, p. 397, doi. 10.1038/362397a0

By:

Gee, Henry;
Gasic, Gregory

Publication type:

Article

Genentech's stance on biodiversity riles staff.

Published in:

Nature, 1992, v. 358, n. 6382, p. 97, doi. 10.1038/358097b0

By:

Lehrman, Sally

Publication type:

Article

How Much Is More Life Worth?

Published in:

2006

By:

Brock, Dan W.

Publication type:

Editorial

ONS Foundation to Fund Outcomes Research and Symptom Management Grants.

Published in:: ONS News, 2001, v. 16, n. 1, p. 6
Publication type:: Article

Genentech: The Beginnings of Biotech.

Published in:

2012

By:

Smith, John K.

Publication type:

Book Review

Study Aims to Clarify Efficacy, Safety of Eye Drug Treatments.

Published in:

JAMA: Journal of the American Medical Association, 2007, v. 297, n. 14, p. 1538, doi. 10.1001/jama.297.14.1538

By:

Mitka, Mike

Publication type:

Article

Response of Diabetic Papillopathy to Intravitreal Bevacizumab.

Published in:

2011

By:

Al-Dhibi, Hassan;
Khan, Arif O.

Publication type:

Case Study

INDUSTRY NEWS IN BRIEF.

Published in:: Ocular Surgery News, 2010, v. 28, n. 14, p. 20
Publication type:: Article

Industry Pipeline.

Published in:: Ocular Surgery News, 2010, v. 28, n. 4, p. 34
Publication type:: Article

Specialist gives pearls on as-needed dosing schedule of anti-VEGF.

Published in:

Ocular Surgery News, 2009, v. 27, n. 21, p. 64

By:

Cimberle, Michela

Publication type:

Article

OCT-guided anti-VEGF therapy may result in undertreatment.

Published in:

Ocular Surgery News, 2009, v. 27, n. 21, p. 62

By:

Bechtel, Bryan

Publication type:

Article

Combination brachytherapy and anti-VEGF therapy demonstrates long-term safety and efficacy.

Published in:: Ocular Surgery News, 2009, v. 27, n. 21, p. 20
Publication type:: Article

Search for optimal anti-VEGF dosing strategy in AMD continues.

Published in:: Ocular Surgery News, 2009, v. 27, n. 21, p. 19
Publication type:: Article

Treat-and-extend treatment protocol may not relieve subretinal fluid, but patients maintain vision.

Published in:: Ocular Surgery News, 2009, v. 27, n. 21, p. 15
Publication type:: Article

BREAKING NEWS.

Published in:: Ocular Surgery News, 2009, v. 27, n. 7, p. 6
Publication type:: Article

Expert offers current facts, figures and arguments on intravitreal bevacizumab.

Published in:

Ocular Surgery News, 2008, v. 26, n. 20, p. 50

By:

Cimberle, Michela

Publication type:

Article

Genentech adopts plan to retain employees after rejecting offer.

Published in:

Ocular Surgery News, 2008, v. 26, n. 18, p. 17

By:

Boyle, Erin L.

Publication type:

Article

Roche proposes to buy outstanding company shares in Genentech.

Published in:

Ocular Surgery News, 2008, v. 26, n. 16, p. 19

By:

Boyle, Erin L.

Publication type:

Article

Genentech reaches agreement with AAO, ASRS on Avastin access.

Published in:: Ocular Surgery News, 2008, v. 26, n. 2, p. 1
Publication type:: Article

Court of Appeal agrees: breast cancer formulation patents to be revoked.

Published in:

Journal of Intellectual Property Law & Practice, 2016, v. 11, n. 12, p. 874, doi. 10.1093/jiplp/jpw157

By:

Kendall-Windless, Carissa;
Sharples, Andrew

Publication type:

Article

Novelty does not necessarily mirror infringement: product-by-process claims.

Published in:

Journal of Intellectual Property Law & Practice, 2015, v. 10, n. 5, p. 318, doi. 10.1093/jiplp/jpv030

By:

Smyth, Darren

Publication type:

Article

Project Aims to Eliminate Disparities in Clinical Trials.

Published in:

ONS Connect, 2008, v. 23, n. 6, p. 20

By:

Ford, Bertie

Publication type:

Article

FDA actions.

Published in:: OB/GYN Clinical Alert, 2010, p. 2
Publication type:: Article

Genentech: The Beginnings of Biotech.

Published in:

2014

By:

ONAGA, LISA

Publication type:

Book Review

THE WEATHERVANE.

Published in:

Hawaii Medical Journal, 2006, v. 65, n. 9, p. 274

By:

Stodd, Russell T.

Publication type:

Article

Capacity Investment with Demand Learning.

Published in:

Operations Research, 2017, v. 65, n. 1, p. 145, doi. 10.1287/opre.2016.1561

By:

Qi, Anyan;
Ahn, Hyun-Soo;
Sinha, Amitabh

Publication type:

Article

New indication.

Published in:: 2009
Publication type:: Product Review

FDA actions in brief.

Published in:: Formulary, 2008, v. 43, n. 4, p. 121
Publication type:: Article

Tarceva.

Published in:: Formulary, 2005, v. 40, n. 12, p. 425
Publication type:: Article

A year of novel pharmacologic agents in review.

Published in:: Formulary, 2004, v. 39, n. 12, p. 572
Publication type:: Article

New molecular entities.

Published in:: Formulary, 2004, v. 39, n. 12, p. 568
Publication type:: Article

Ranibizumab: A Viewpoint by Steven D. Schwartz.

Published in:: Drugs, 2007, v. 67, n. 8, p. 1207
Publication type:: Article

MEDWATCH: Company Recalls Psoriasis Drug, FDA Issues Warning on Skin Patches.

Published in:: American Family Physician, 2009, v. 79, n. 9, p. 734
Publication type:: Article

Concern over AMD patients' access to Avastin.

Published in:: Expert Review of Ophthalmology, 2007, v. 2, n. 6, p. 897
Publication type:: Article

INNOVATION INC.

Published in:

Berkeley Technology Law Journal, 2017, v. 32, n. 2, p. 713, doi. 10.15779/Z38NP1WJ41

By:

Plamondon Bair, Stephanie

Publication type:

Article

DETHRONING LEAR? INCENTIVES TO INNOVATE AFTER MEDIMMUNE.

Published in:

Berkeley Technology Law Journal, 2009, v. 24, n. 2, p. 971

By:

Dreyfuss, Rochelle Cooper;
Pope, Lawrence S.

Publication type:

Article

CITY OF HOPE V. GENENTECH: KEEPING FIDUCIARY DUTIES WHERE THEY BELONG.

Published in:

Berkeley Technology Law Journal, 2009, v. 24, n. 1, p. 179

By:

McBride, Reed C.

Publication type:

Article

DECLARATORY JUDGMENT ACTIONS IN PATENT CASES: THE FEDERAL CIRCUIT'S RESPONSE TO MEDIMMUNE V. GENENTECH.

Published in:

Berkeley Technology Law Journal, 2008, v. 23, n. 1, p. 161

By:

Saionz, Jennifer R.

Publication type:

Article

Biotechnology: DNA dollars.

Published in:

2011

By:

Ostroff, Linnaea

Publication type:

Book Review

Roche vows to keep Genentech culture.

Published in:

Nature, 2009, v. 458, n. 7236, p. 270, doi. 10.1038/458270a

By:

Hayden, Erika Check

Publication type:

Article

Roche launches hostile bid for Genentech shares.

Published in:: Nature, 2009, v. 457, n. 7230, p. 648, doi. 10.1038/457648a
Publication type:: Article

Making the paper: Wei-Qiang Gao.

Published in:: Nature, 2008, v. 456, n. 7223, p. xiii, doi. 10.1038/7223xiiia
Publication type:: Article

Omalizumab: Anti-IgE monoclonal antibody E25, E25, Humanised anti-IgE MAb, IGE 025, Monoclonal antibody E25, Olizumab, Xolair, rhuMAb-E25.

Published in:: BioDrugs, 2002, v. 16, n. 5, p. 380, doi. 10.2165/00063030-200216050-00009
Publication type:: Article